Exagen Market Cap

Exagen has a market cap or net worth of $137.79 million as of January 9, 2026. Its market cap has increased by 51.70% in one year.

Market Cap

137.79M

Enterprise Value

132.35M

1-Year Change

51.70%

Ranking

#4037

Market Cap Chart

Since September 19, 2019, Exagen's market cap has increased from $63.11M to $137.79M, an increase of 118.35%. That is a compound annual growth rate of 13.18%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	139.83M	1.48%
Dec 31, 2025	137.79M	90.55%
Dec 31, 2024	72.31M	113.18%
Dec 29, 2023	33.92M	-13.39%
Dec 30, 2022	39.17M	-79.17%
Dec 31, 2021	187.99M	12.56%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Sep 19, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.72B
Johnson & Johnson	493.40B
AbbVie	395.77B
UnitedHealth Group	316.11B
AstraZeneca	293.89B
Merck & Co.	270.22B
Novartis AG	268.87B
Novo Nordisk	253.02B

Market Cap Rankings